Intracranial pressure may be just as critical of a factor in the progression of glaucoma as IOP, according to a speaker here ...

John Berdahl, MD, discusses a non-surgical, non-drug treatment for glaucoma approved by the FDA in 2024. The pump uses negative pressure to lower eye pressure by an average of 39% in clinical trials, ...

Spaceflight-linked neuro-ocular syndrome, or SANS, affects astronauts' vision due to microgravity-induced fluid shifts ...

Qlaris Bio is seeing double when it comes to phase 2 wins for its eye drug, hitting the primary endpoints in trials that both spanned primary open angle glaucoma (POAG) and ocular hypertension (OHT).

A combination of low blood pressure and high intraocular pressure can predict RNFL thinning in moderate-to-severe glaucoma.

The low levels of gravity (microgravity) in space cause significant changes in astronauts' eyes and vision after six to 12 ...

Intraocular pressure (IOP) is the only modifiable risk factor for glaucoma ... e.g., to stratify individuals into high and low risk groups, and to infer possible causal effects. Since the first ...

Additionally, carbonic anhydrase inhibitors, which are often used to lower intraocular pressure in glaucoma patients, have also been linked to serious adverse events, including angle-closure glaucoma.

Glaucoma is a complex group of eye diseases that lead to progressive dam- age to the optic nerve, often associated with increased intraocular pressure (IOP). It is one of the leading causes of ...